Top 50 Health Care Angel Investors in Israel (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Marius Nacht
Angel
|
5 | Israel, United States, Germany | Series A, Seed | Artificial Intelligence, Health Care, Machine Learning | $3M–$120M |
|
Zohar Gilon
Angel
|
3 | Israel, United States | Seed, Series A, Series B | Software, Internet, Health Care | $1.5M–$15M |
|
Howard Morgan
Angel
|
3 | United States, Israel, India | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $857k–$85M |
|
Ran Tuttnauer
Angel
|
3 | Israel, Canada, United States | Seed, Series A | Health Care, Big Data, Internet | |
|
Assaf Wand
Angel
|
2 | United States, Brazil, France | Seed, Series A, Pre-Seed | Insurance, Software, Health Care | $2.8M–$42M |
|
Yehuda Zisapel
Angel
|
2 | Israel | Series A, Seed | Medical Device, Medical, Health Care | |
|
Yaron Samid
Angel
|
2 | United States, Israel, Brazil | Seed, Pre-Seed, Series A | Software, Apps, SaaS | $2M–$47M |
|
Shimon Eckhouse
Angel
|
2 | Israel | Seed | Medical, Biotechnology, Fitness | |
|
Oren Dobronsky
Angel
|
2 | United States, Israel | Seed, Series A, Angel | FinTech, Payments, Software | $1M–$17M |
|
Eyal Gura
Angel
|
2 | United States, Israel, Belgium | Series A, Seed, Series B | Software, Mobile, Health Care | $1M–$40M |
|
Jonathan Karten
Angel
|
2 | Israel, United States, Canada | Seed, Angel, Pre-Seed | Software, B2B, Marketing | $100k–$10M |
|
Danny Hadar
Angel
|
2 | Israel, United States | Seed, Series B | Software, Artificial Intelligence, Internet | $65k–$11M |
|
Moshe Gaon
Angel
|
2 | Israel, United States | Seed, Series A, Convertible Note | Advertising, SaaS, Music | |
|
Mazal CB
Angel
|
2 | Israel | Seed, Pre-Seed | Health Care, Therapeutics, Medical Device | |
|
Sake Bosch
Angel
|
2 | The Netherlands, France, Israel | Seed, Series A, Series B | Software, E-Commerce, Biotechnology | $1.9M–$77M |
|
Prof. Rafael Beyar
Angel
|
2 | Israel | Seed, Series A | Medical, Medical Device, Machine Learning | $1M–$17M |
|
Ron C
Angel
|
2 | Israel | Seed, Pre-Seed | Health Care, Therapeutics, Medical Device | |
|
Avishai Abrahami
Angel
|
2 | Israel, United States, Italy | Seed, Pre-Seed, Series A | Software, Information Technology, Apps | $250k–$9.5M |
|
Shane Neman
Angel
|
1 | United States, Kenya, Spain | Seed, Series A | Health Care, Software, Artificial Intelligence | |
|
David Agus
Angel
|
1 | Israel | Series A | Health Care, Health Diagnostics, Artificial Intelligence | |
|
Romain Afflelou
Angel
|
1 | France, United States, Israel | Seed, Series A, Pre-Seed | Health Care, FinTech, Software | |
|
Mandeep Singh
Angel
|
1 | United Kingdom, United States, Germany | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | |
|
Amiad Solomon
Angel
|
1 | Israel, United States | Seed, Pre-Seed, Series A | Nutrition, Food Processing, Loyalty Programs | |
|
Yasmin Lukatz
Angel
|
1 | Israel | Seed, Pre-Seed | Medical, Consumer, Wellness | |
|
Raoul Stein
Angel
|
1 | Israel | Pre-Seed | Medical, Health Care, Therapeutics | |
|
Nir Greenberg
Angel
|
1 | Israel | Angel, Pre-Seed | Advice, Medical, Software | |
|
Lyndon Babtiste
Angel
|
1 | Israel | Seed | mHealth, Blockchain, Health Care | |
|
Edward Lando
Angel
|
1 | United States, France, United Kingdom | Seed, Pre-Seed | Software, Health Care, Information Technology | |
|
Brock Weatherup
Angel
|
1 | Israel, United States | Seed | EdTech, Medical, mHealth | |
|
Lewis Pell
Angel
|
1 | Israel, United States | Post-IPO Equity | Health Care, Medical, Therapeutics | |
|
Nir Kalkstein
Angel
|
1 | Israel | Seed, Series B | Machine Learning, Health Care, Artificial Intelligence | |
|
Ariel Yaar
Angel
|
1 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, CRM | |
|
Larry Ellison
Angel
|
1 | United States, Spain, Israel | Series C, Series B | Software, Health Care, Biotechnology | |
|
Zohar Zisapel
Angel
|
1 | Israel, United States | Series A, Seed, Series B | Cyber Security, Information Technology, Security | |
|
Nadav Lurie
Angel
|
1 | Israel | Series A | Consulting, Health Care, Professional Services | |
|
Chris Mansi
Angel
|
1 | United States, Israel | Series A | Health Care, Medical, Software | |
|
Jacques R. Seguin
Angel
|
1 | Israel, Switzerland | Seed, Pre-Seed | Medical, Medical Device, Health Care | |
|
Joshua Riff
Angel
|
1 | Israel | Seed | Software, Wellness, Analytics | |
|
Rafi Gidron
Angel
|
1 | Israel, United States, United Kingdom | Seed, Angel, Series B | Artificial Intelligence, Cyber Security, Financial Services | |
|
Tzachi Arabov
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Laurence Modiano
Angel
|
1 | Israel | Series A | Consulting, Health Care, Professional Services | |
|
Robert Nelsen
Angel
|
1 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $13M–$217M |
|
Lily Sarafan
Angel
|
1 | United States, Israel | Seed, Series A | Health Care, Wellness, Enterprise Software | |
|
Ron Sabar
Angel
|
1 | Israel | Seed | Health Care, Bioinformatics, Personal Health | |
|
Anne Wojcicki
Angel
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | |
|
Sir Ronald Cohen
Angel
|
1 | Israel, United States, United Kingdom | Series A, Seed | Health Care, Financial Services, Apps | $1.7M–$100M |
|
Beni Nofech
Angel
|
1 | Israel | Pre-Seed, Series A | Food and Beverage, Food Processing, Nutrition | $450k–$2M |
|
Riccardo Zacconi
Angel
|
1 | United States, Sweden, Estonia | Seed, Series A, Series B | Gaming, Apps, Mobile | $700k–$56M |
|
Noam Solomon
Angel
|
1 | Israel | Seed | Software, Wellness, Health Care | |
|
Dov Moran
Angel
|
1 | Israel, United States | Seed, Series A, Series B | Hardware, Health Care, Semiconductor | $1.2M–$83M |
| Access all 99 angel investors in Israel Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Machine Learning
- Stage:Series A, Seed
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 33
- Round size: Seed $3M–$120M; Series A $5M–$23M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
- WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
- Ultima Genomics — Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more...Investment focus
- Industry: Software, Internet, Health Care
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 33
- Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley. Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal. Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences. Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, India
Investor stats
- Total investments: 79
- Round size: Seed $1M–$6.3M; Series A $2M–$85M; Series B $857k–$28M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Aktivate — Aktivate provides a SaaS based tecnology platform for K-12 schools to manage and fund scholastic sports. The system features administration and engagement tools to bring together student-athletes, their families, schools, and valued partners.
- NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
- HATCH — HATCH is the first of its kind Giving Intelligence Platform. An AI-powered portal for Fundraisers, Marketers and Volunteers to streamline and Maximize their impact. A new home for a new world of giving!
Ran Tuttnauer
Show more...Investment focus
- Industry: Health Care, Big Data, Internet
- Stage:Seed, Series A
- Geography: Israel, Canada, United States
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Innovopro — InnovoPro is committed to bringing unique plant-based protein ingredients to the global food market in order to create nutritious, tasty, safe, and sustainable food products. With an excellent nutritional profile, free from properties and wide usability in the food industry, InnovoPro’s chickpea protein is the best choice for the growingplant-based protein market.InnovoPro was founded on 2013 by Dr. Ascher Shmulewitz an experienced inventor and investor, and has made considerable progress in developing chickpea proteins and other chickpea ingredients.InnovoPro has been recognized as an innovator of disruptive technology in the food industry.
- Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
- Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.
Assaf Wand is the Founder and Executive Chairman of Hippo Insurance. He previously worked at Sabi Sold to Urbio as a Founder and CEO. Assaf Wand attended the University of Chicago.
Show more...Investment focus
- Industry: Insurance, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Brazil, France
Investor stats
- Total investments: 13
- Round size: Seed $2.8M–$15M; Series A $8M–$42M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Fairmatic — Powered by data and AI, focused on rewarding fleet safety with savings. Finally, a smarter insurance option designed to put fleets in control.
- Segura — Segura equips brokers with tech and top insurer access for the future of insurance.
- Carecode — Carecode system combines powerful Generative AI models with continuous learning mechanisms, enabling natural and autonomous interactions that adapt to complicated environments without the need for human intervention.
Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Seed
- Geography: Israel
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Carteav — Autonomous Low Speed Vehicle
- Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
- Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.
Yaron Samid is an Israeli-American technology entrepreneur, investor, and startup community builder. Yaron is the founder of TechAviv, the 3K-member global Israeli startup founders club, and is the managing partner of TechAviv Founder Partners, a pre-seed venture fund, backed and powered by over 100 of the world’s most successful company builders.Previously, Yaron was the founder and CEO at BillGuard (Acq. by Prosper), founder & CPO at Pando (Acq. by Microsoft), and a founding board director at CloudLock (Acq. by Cisco) and Pond5.Yaron lives in Tel Aviv with his family and is a regular guest lecturer at Stanford and Columbia Business School. He attended Technion - Israel Institute of Technology and the University of Maryland.
Show more...Investment focus
- Industry: Software, Apps, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Israel, Brazil
Investor stats
- Total investments: 21
- Round size: Seed $4M–$39M; Pre-Seed $2M–$5.3M; Series A $9M–$47M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- bxblue — bxblue is a marketplace for personal loans in Brazil explicitly targeting pensioners and Government workers because they can they take loans secured by their guaranteed income. Because of that banks can deduct the payment directly from the paycheck, leading to an apr 10x lower than credit cards. Payroll secured loans are the most affordablepersonal loan in Brazil, and they represent 60% of the personal loans in the country. It is a 40bn dollar/year marke, completely offline. We are taking this entire market online.
- Emedgene — Applying machine learning to genomics. Accelerate NGS data analysis and automate variant classification with evidence curated from the literature. From sample to report.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
Shimon Eckhouse
Show more...Investment focus
- Industry: Medical, Biotechnology, Fitness
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Entrepreneur at heart. Angel investor in past two decades. I had the privilege to invest in the following startups, mostly at seed level: Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens... But mostly, I am known as Oren from Oren's Hummus :)
Show more...Investment focus
- Industry: FinTech, Payments, Software
- Stage:Seed, Series A, Angel
- Geography: United States, Israel
Investor stats
- Total investments: 13
- Round size: Seed $1M–$17M; Series A $2M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Linguana — Linguana builds and monetizes your fully localized YouTube channels in new languages to reach new audiences across the globe and monetize them.
- Openbase — Find and compare the best open-source packages in hundreds of categories - withpowerful metrics and user reviews
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).
Show more...Investment focus
- Industry: Software, Mobile, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Belgium
Investor stats
- Total investments: 26
- Round size: Seed $1M–$3.6M; Series A $7.1M–$40M; Series B $14M–$21M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Taranis — Taranis offers cutting-edge crop & farm management software for precision agriculture. Increase efficiency and yield. Learn more now.
- Imagene AI — Imagene AI is a pioneer in multimodal foundation models for precision medicine, advancing translational research and clinical development. We make every trial more responsive, every insight more actionable, and every patient journey more personalized.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Principal at Awz Ventures | Advancing Israel’s Economic & Technological Resilience Investing in deep-tech innovations across AI, cybersecurity, photonics, biotech, and quantum technologies to strengthen Israel’s economy and defense capabilities. Veteran Staff Sergeant in the Israeli Air Force Intelligence division, Horizon. MSc BusinessAnalytics & BA Financial Economics, Psychology & Business Management; Columbia University Magna Cum Laude.• Former President and Founder of Democratize Value (VC) • Former President and Founder of The Iftach Consulting Group (Management Consulting)My recent accomplishments include: • Raising $8 million from angel investors and due diligence/investing in 27 ventures in PropTech, E-commerce, Marcom, Healthcare, and FinTech sectors • Providing fundraising, due diligence, marketing, and operational advice to 23 PropTech, FinTech, and other Israeli start-ups • Underwriting, modeling, sourcing capital, negotiating, and closing 100+ commercial real estate transactions in the US, Israel, and EuropeOn the personal side, I: • Created a documentary called “Survival In The Forest, Isidore Karten & The Partisans”. • Served in the Israeli Air Force (SSG in Business Intelligence Division) • Volunteer as a Board Member with Yad Va Shem and the Israeli American CouncilSkills Global Early-Stage Startups | Venture Capital| Business Valuation | Account Management | Arabic | Business Strategy | Data Analysis | Financial Reporting | Foreign Relations| Hebrew | Management Consulting | Public Speaking | Social Media | Statistical Data Analysis | Strategic Communications | Team Leadership | Arab-Israel Conflict | Business Valuation | Client-Focused | Customer Relationship Management (CRM) | Commercial Real Estate Acquisition | Commercial Real Estate Analysis | Commercial Real Estate Development | Competitive Analysis | Corporate Finance | Corporate Venture Capital| Creative Entrepreneurship | Early-Stage Investment | Early-Stage Ventures| Debt & Equity Capital Raising| Debt & Equity Financing | Entrepreneurship Development| Financial Analysis | Financial Modeling | Fintech| Fundraising | Global Cross Functional Team Leadership | International Business Development | International Trade Relations | Investment Communications | Management Due Diligence| Market Research | New Business Development |Operational Due Diligence| Private Equity Firms | Proptech | Real Estate Private Equity | Residential Real Estate Sales | Startup Development | Start-Ups | Valuation Modeling
Show more...Investment focus
- Industry: Software, B2B, Marketing
- Stage:Seed, Angel, Pre-Seed
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 15
- Round size: Seed $150k–$10M; Pre-Seed $100k–$250k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MyQuest — myQuest enables you to engage customers and employees anywhere, anytime. Easily train and interact with learners using AI, micro-learning, and gamification.
- Immagnify Ltd. — Immagnify provides business teams with accurate B2B contact information based on advanced technographic segmentation and customer analysis.
- DayDream Ventures — DayDream Ventures is a venture fund investing in founders building with community-led growth in mind in.
For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 23
- Round size: Seed $65k–$11M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
- Deci AI — Deci enables deep learning to live up to its true potential by using AI to build better AI. With the company’s end-to-end deep learning acceleration platform, AI developers can build, optimize, and deploy faster and more accurate models for any environment, including cloud, edge or mobile. With Deci’s platform, developers can increase deeplearning model inference performance by 3x-15x, on any hardware, while still preserving accuracy. This translates directly into new use cases on limited hardware, substantially shorter development cycles, and reduced compute costs by up to 80%. The platform is powered by Deci’s Automated Neural Architecture Construction (AutoNAC) technology, an algorithmic optimization engine that squeezes maximum utilization out of any hardware. The AutoNAC engine contains a Neural Architecture Search (NAS) component that redesigns a given trained model’s architecture to optimally improve its inference performance (throughput, latency, memory, etc.) for specific target hardware while preserving its baseline accuracy. Deci achieved a record-breaking 11.8x accelerated inference speedup on Intel CPUs at MLPerf Industry Benchmark and has been named to the CBInsights top 100 AI companies. Led by a team of world-class deep learning experts, Deci lets AI developers focus on what they do best - creating innovative AI-based solutions for our world’s most complex problems.
- Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.
Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.
Show more...Investment focus
- Industry: Advertising, SaaS, Music
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Apester — Supercharge your marketing and funnel with interactive content experiences that generate more leads, engage and convert users, and boost retention
- Yoocan — Yoocan is a global community for people with disabilities and their families, discover empowering stories, find support, and connect with a world that understands you.
- IndieFlow — IndieFlow developed a workflow management platform for the music industry. The platform provides a centralized platform to manage music industry workflows and streamline the major building blocks of an artist’s career. It enables users to manage creative projects, distribute to streaming platforms, collect roylaties, register music with royaltycollection societies, promote music, book gigs, receive payments and more.
Mazal CB
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.
Show more...Investment focus
- Industry: Software, E-Commerce, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: The Netherlands, France, Israel
Investor stats
- Total investments: 31
- Round size: Seed $1.9M–$9.5M; Series A $6.9M–$29M; Series B $7.1M–$77M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- LionVolt — LionVolt is a battery startup company that claims to develop the most efficient solid state lithium-ion battery.
- Fairbrics — Fairbrics is developing the first synthetic fiber with a net positive impact on climate change and capable of meeting the demand of the market.
- Multus — Key ingredients for the affordable scale-up of cellular agriculture
Prof. Rafael Beyar
Show more...Investment focus
- Industry: Medical, Medical Device, Machine Learning
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Series A $1M–$17M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
Ron C
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Avishai Abrahami is our Co-Founder, has served as our Chief Executive Officer since September 2010 and was our Co-Chief Executive Officer and a director since October 2006. From 2004 to 2006, Avishai was the Vice President of Strategic Alliances at Arel Communications & Software Ltd., a private Israeli company specializing in communicationtechnology. In 1998 he co-founded Sphera Corporation, a private company which develops software for managing data centers, and he served as its Chief Technology Officer from 1998 until 2000 and its Vice President of Product Marketing from 2000 until 2003. In 1993, he co-founded AIT Ltd., a private Israeli software company, and served as its Chief Technology Officer until the company's sale in 1997. Avishai served in the Israeli Defense Forces' elite computer intelligence unit from 1990 until 1992.
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Italy
Investor stats
- Total investments: 14
- Round size: Seed $250k–$9.5M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Era — An AI-based fertility copilot that optimizes time, cost, and the overall experience for both fertility providers and parents on their path to parenthood
- nexos.ai — Introducing nexos.ai — a powerful model gateway that delivers game-changing AI solutions. With advanced automation and intelligent decision making, nexos.ai helps simplify operations, boost productivity, and accelerate business growth.
- CustoMED — CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence.
Founder of EZ Texting and JoonBug. Serial entrepreneur and investor in Tech, Real Estate & Hospitality.cA forward-thinking problem solver, consummate optimist and serial entrepreneur, Shane Neman is the prototypical businessman of our modern era. His experience and expertise in business span numerous industries, from technology andtelecommunications to real estate and hospitality. After leaving NYU Medical School early, he started three industry-shifting tech startups (two of them – EZ Texting and JoonBug – acquired) with hundreds of employees and tens of thousands of customers. As an insightful startup backer, Shane’s portfolio includes companies such as Convoy, Prose, Impossible Foods, Universal Standard, Apostrophe, MeetMindful, MapAnything, VinePair and Smylen. Shane is also a prolific real estate developer and investor. From commercial shopping and industrial centers to residential buildings, he owns more than two dozen large-scale properties across the U.S. He holds a degree in Computer Science from New York University, where he received the prestigious Barry M. Goldwater scholarship and was a member of the Phi Beta Kappa academic honor society.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United States, Kenya, Spain
Investor stats
- Total investments: 98
- Lead/follow: no public data
Portfolio highlights
- Endiatx — Endiatx is a medical device manufacturing company that specializes in developing a series of pill-sized robots to perform remote diagnosis. Its unique propulsion system which allows our pill robots to actively navigate the entire length of the GI tract is approximately 30 minutes with real-time video control.It was founded in 2019 andheadquartered in Redwood City, California.
- Nara Organics — Introducing a whole new standard for infant formula. Nara Organics is built on the healthy fats in organic whole milk.
- SpaceX — SpaceX designs, manufactures and launches advanced rockets and spacecraft.
Dr. David B. Agus is one of the world’s leading doctors and pioneering biomedical researchers. He is the founding director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine and a professor of medicine and engineering at the University of Southern California. A medical oncologist, Dr. Agus leads a multidisciplinary team ofresearchers dedicated to the development and use of technologies to guide doctors in making health-care decisions tailored to individual needs. An international leader in global health and approaches for personalized healthcare, Dr. Agus serves in leadership roles at the World Economic Forum and is co-chair of the Global Health Security Consortium. He is also a CBS News contributor. Dr. Agus’ three books The End of Illness, A Short Guide to a Long Life, and The Lucky Years: How to Thrive in the Brave New World of Health, are all New York Times and international bestsellers, with a new book, The Book of Animal Secrets: Nature’s Lessons for a Long and Happy Life, set for release in March 2023. He is a 2017 recipient of the Ellis Island Medal of Honor.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Artificial Intelligence
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Imagene AI — Imagene AI is a pioneer in multimodal foundation models for precision medicine, advancing translational research and clinical development. We make every trial more responsive, every insight more actionable, and every patient journey more personalized.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Romain spearheaded the digital strategy of Alain Afflelou Group before becoming an investor in numerous start-ups. He uses his fine-tuned analysis skills to support and invest in innovative start-ups. In addition to being a major shareholder and Co founder of Cosmo Connected a French start-up specialized in connected objects related to security andmobility.Romain is Director and Board member of Multiwave Technologies /develops breakthrough metamaterial technologies to improve people's lives.Serial investor in +50Tech companies6over6 (Acquired by 1-800 contacts) Cityscoot Clay Inc VR Cowboy Bike Epicery Everoad (Ex Convargo) Fithouse Fré Skincare Fokoya Guillotine Vodka Klassroom Laminate Technologies MeetFabric Molotov TV Multiwave Technologies Nestor Octopus Officeriders Onoff telecom Pledg Quiqup Universal Standard Shapr Spendesk Zipdrug...(Acquire by Anthem Pharmacy)
Show more...Investment focus
- Industry: Health Care, FinTech, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: France, United States, Israel
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- Cashbee — Cashbee is a mobile application to helps save money with budget analysis tools based on artificial intelligence. They wish to help the French to save better and more, and to provide the technological means to do this in the simplest possible way, without having to change banks. The Cashbee App allows you to put money aside with a simple swipe onyour smartphone. They alert you every time when they think you can put some more cash aside.
- Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
- Kubo Labs — Kubo Labs provides a suite of products to simplify your experience with Kubernetes.
Mandeep Singh is an Angel investor at multiple firms. He previously was the founding CEO at Trouva. Mandeep Singh studied Physics at the University of Cambridge.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 74
- Lead/follow: no public data
Portfolio highlights
- Droidrun — Droidrun is a cutting-edge software development company that specializes in creating innovative solutions enabling AI agents to seamlessly access and control smartphone applications. By leveraging advanced artificial intelligence and machine learning algorithms, their software facilitates smooth interactions between AI systems and mobile devices,empowering agents to autonomously navigate, operate, and optimize a wide range of apps on both Android and iOS platforms.
- Stackfix — Stackfix operates as a software comparison platform.
- Fractile — Fractile is designing AI compute systems that will enable the next generation of AI scaling: frontier model inference, 25x faster, at 1/10th the cost.
Amiad Solomon is the CEO and Founder of HQ. He previously worked at Komoona as a Founder and Chairman.
Show more...Investment focus
- Industry: Nutrition, Food Processing, Loyalty Programs
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
- Snowmate — Snowmate's disruptive technology finds backend bugs fully automatically and at the earliest stages of the development cycle - no AI, no magic tricks, but pure deep tech only.
- ANYBODIES — Anybodies is the first enterprise customer engagement platform for creating NFT based loyalty programs for creators, brands and enterprises.
Yasmin Lukatz is the Founder and Executive Director of ICON. She attended Stanford Graduate School of Business.
Show more...Investment focus
- Industry: Medical, Consumer, Wellness
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
- Arya — Arya is building the Couples Wellness category, poised to become the next billion-dollar cornerstone in the global wellness market.Couples are falling into routine and many are experiencing increased loneliness. While billions are spent on fitness, mindfulness, and sleep, emotional and physical intimacy is often neglected. We invest in swipingfor the right partner and then trying to fix it (or spend a fortune divorcing them)... but not much in between.Arya's AI concierge makes it radically easy for couples to invest in their relationship and love life, both inside and outside the bedroom - a crucial ingredient to a successful relationship.
- PointFive — PointFive provides ongoing cloud cost savings by providing deeper detection and collaborative repair solutions that fit smoothly into teams' normal operations.
Raoul joined Kreos in 1999 and over the last 12 years has built a highly active presence as the leading senior credit provider to high-growth companies in Israel, as well as supporting a wide range of transactions across Europe. Mr. Stein also plays a key role in the management and execution of Kreos's overall strategy.Before joining Kreos,Raoul was an associate with Apax Partners in Israel where he invested in services and high-growth technology businesses and corporate spin-offs. He also assisted the general partners in fund-related activities such as divestment of their funds' successes traded on NASDAQ, and in general fund-raising activities such as portfolio analysis, reporting and due diligence for the purpose of raising new funds.Prior to joining Apax Partners, Raoul was an associate with Friedman , Turbidy & Co, a New York-based financial advisory firm. Raoul assisted the managing partner in several refinancing and acquisition transactions. He was involved in a refinancing of asset-backed loans with a large glass maker in the US, representing the company in its efforts to refinance its debt with banking institutions. In addition he was involved in fund-raising for a US based cosmetics company in its expansion.Raoul studied law at Bar-Ilan University. He clerked at the firm of M. Porath & Co in Tel-Aviv and passed the Bar exams in Israel in 1993. After that he graduated in 1995 from Columbia Business School with an MBA.
Show more...Investment focus
- Industry: Medical, Health Care, Therapeutics
- Stage:Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burdens. Learn more.
Founder and CEO at Natural Intelligence.
Show more...Investment focus
- Industry: Advice, Medical, Software
- Stage:Angel, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burdens. Learn more.
- Superfy — Superfy gets you an answer to any question from a relevant person, using superior AI for matching people.With Superfy getting answers is simple. You ask a question, and Superfy connects you in chat with another user who already knows the answer. If you want to know the weather or exchange rates - go to Google; if you want to know what’s it liketo work at Google - ask Superfy!Superfy’s Machine Learning algorithms (US utility patent-pending) replace traditional NLP methods to crack the challenge of analyzing unstructured User Generated Content across all verticals.We launched our public iOS beta last December, and the stats are promising: 87% of our users are asking questions, 46% of our users are answering questions - over 10x the industry standard! Our users love Superfy, spending 9 minutes a day on the app, and calling it “cool”, “addictive”, “super-friendly” and “helpful” (rated 4.4 on the US Appstore).Download (iOS): https://apple.co/2CZ3HjI Or search Superfy on the App Store.Superfy was founded by Gil Schoenberg and Michal Tamir, a married couple with years of startup experience in Business, Marketing and mostly Product, both for B2C and B2B. Among our advisors is Avishai Abrahami, Wix Founder & CEO, who paved the way for Israeli B2C startups.
Lyndon Babtiste
Show more...Investment focus
- Industry: mHealth, Blockchain, Health Care
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Proof Work — Proof puts patients medical data on a decentralized secure platform and ledger for personal ownership, interoperability and a lifetime history of care. For free. In two minutes your health data is secured on the blockchain. It's as easy as that.Our solution makes data more private and liquid costs less to administer and provides a real-timelifesaving flow of medical data.This same medical data becomes an intrinsic valuable digital passport arising from the users prerogative for permission-based access control.Rights can be granted or traded to either another patient, payer or provider such as doctor, insurer, hospital, pharmacy, nurse, caregiver, family or friend.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 311
- Lead/follow: no public data
Portfolio highlights
- Swaive — Swaive operates a financial firm that invests in risk-free instruments. The organization allows you to park your money without risk.
- Volta — Volta is a developer of software-as-a-service platform focusing on B2B commerce.
- Hidden Studios — Hidden Studios develops and advertises Fortnite Creative games, with 100M+ plays monthly. The company collaborated with prominent brands and creators, including Skydance, Snoop Dogg, and CaseOh, to deliver engaging gaming experiences. Hidden Studios maintains an active presence on YouTube, sharing content related to their Fortnite Creativeendeavors.
Brock Weatherup is the CEO/Founder of Metamorphosis Partners driving enterprise value through innovation in the $80B pet industry focused on the consumer. Brock was most recently the EVP of Strategic Innovation & Digital Experience at Petco. Previously he was CEO & CoFounder of PetCoach (acquired by Petco) - revolutionizing the PetHealth Care experience. Brock is a CEO, entrepreneur, angel investor, builder of enterprise value and passionate advocate about the consumer and their interactions with digital media & Ecommerce. Brock is also managing partner of Atai Ventures angel investments, co-founder of ICONYC (www.iconyclabs.com) an early stage NYC based Israeli accelerator, investor/advisor/board member for 7+ startups - VeryApt, SideCar, Social Ladder, Ethology and an industry advisor for VC firms EQT Partners, MissionOG & SafeGuard. Previously Brock was SVP/Chief Digital Officer of Petsmart after selling Pet360 where he was CEO the prior 5 years. Brock was also CEO of Fathead and held several leadership positions with InterActiveCorp (Ticketmaster, Match.com, CitySearch, ReserveAmerica). A graduate of University of Colorado Boulder, sits as a board member of the Nature Conservancy – Adirondacks, father of two amazing girls and pet owner to my 4yr old retriever named...Boulder.
Show more...Investment focus
- Industry: EdTech, Medical, mHealth
- Stage:Seed
- Geography: Israel, United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Myndlift — Myndlift offers a therapist-guided home neurofeedback solution for mental health, using mobile and wearable technology. Home users enjoy accessible and affordable training while neuro-therapists can grow their practices with remote supervision.
- Amplio — Discover Amplio's innovative platform for speech-language and dyslexia interventions. Streamline educator workloads with evidence-based programs and real-time progress monitoring, ensuring every student receives the individualized support they need.
Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Post-IPO Equity
- Geography: Israel, United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
- Vision Sciences — Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes,otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nir Kalkstein is an entrepreneur, a data scientist and a recognized expert in Big Data and machine learning algorithms. Nir co-founded Final, one of the most successful algo-trading companies worldwide. In 2009 He co-founded Medial with the vision of creating data-driven best-in-class predicative tools that provide physicians with actionableinsights to save lives. Nir has devoted significant intellectual and financial resources to support the ongoing success of the research for the Company, initially as the sole financier, and is committed to reinvesting his future profits into further research. Nir holds a BSc in Electrical Engineering from the Israeli Technion Institute of Technology.
Show more...Investment focus
- Industry: Machine Learning, Health Care, Artificial Intelligence
- Stage:Seed, Series B
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Nucleai — Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
- Medial EarlySign — Medial EarlySign develops an AI algorithmic platform for the discovery of clinical insights that indicate the likelihood of disease from basic medical information, such as blood test results, and other EMR data. Called AlgoMarkers, its predictive engines are built in collaboration with healthcare organizations, through the combination of 10s ofmillions of patient years-worth of data, clinical rigor and some of the most brilliant algorithmic minds. The company develops clinical decision support and population health solutions that can assist in the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases. These tools are designed to place at the fingertips of healthcare organizations only those insights that could prove critical in disease management and prevention empowering them with proactive, predictive and personalized care management capabilities
Ariel Yaar - VP Research and Development @ Readz
Show more...Investment focus
- Industry: Software, Health Care, CRM
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- GearEye — Gear Eye: the ultimate tracking solution for your gear. Manage and locate your equipment tagged with battery-free RFID tags and stickers. Never lose your items.
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
- BioChange Ltd. — BioChange has developed a breakthrough technology for tissue regeneration.
Larry Ellison is the Co-Founder, Executive Chairman, and CTO of Oracle. He attended the University of Chicago.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series C, Series B
- Geography: United States, Spain, Israel
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Imagene AI — Imagene AI is a pioneer in multimodal foundation models for precision medicine, advancing translational research and clinical development. We make every trial more responsive, every insight more actionable, and every patient journey more personalized.
- Kosmos Tennis — Kosmos Tennis is pleased to announce the launch of www.daviscupfinals.com, which will be operational as of 22nd January, to keep the public informed about all aspects of the new Davis Cup Finals. The new website provides easy and intuitive access to all aspects of the new competition format, especially the finals, which will bring 18 national teamstogether in the same city over the course of a week. The new website will also report on the most significant events of the qualifiers set to take place in February.
- Quark Pharmaceuticals — Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the “BiFAR†technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for theoccurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.
Zohar Zisapel
Show more...Investment focus
- Industry: Cyber Security, Information Technology, Security
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
- Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
- Hailo — Hailo have developed the best performing AI processors for edge devices. Our AI accelerator chips are used for Smart City & Homes, machine learning, automotive AI, retail AI and smart factory Industry 4.0 solutions.
Nadav Lurie is the Employee at LURIE PROJECTS.
Show more...Investment focus
- Industry: Consulting, Health Care, Professional Services
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Droxi — Droxi is an AI-based platform that helps primary care physicians to reduce the amount of time spent on non-patient-facing tasks.
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, buildingand supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A
- Geography: United States, Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Canopy — Canopy's intelligent care platform enables practices to improve cancer patients' experience and outcomes in an ever changing oncology environment.
- HumanFirst — HumanFirst enables better integration and analysis of digital health technologies in clinical trials.
- NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.
Jacques Seguin is the Chairman Of The Board at Emanate Biomedical. He Attended Paris-Sud University (Paris XI) during 1975-1985.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Seed, Pre-Seed
- Geography: Israel, Switzerland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Pi-Cardia — Pi-Cardia. Next Generation Valve Repair. The next frontier of treatment options for structural heart disease that provides a safe, effective, and affordable non-implant-based catheter solutions.
- Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Josh Riff is the co-founder of Included Health.
Show more...Investment focus
- Industry: Software, Wellness, Analytics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Laguna Health — Laguna is a tech company solving a huge, costly problem in US healthcare. We provide easier post-hospitalization recovery soultions.
Rafi Gidron is the Chairman and Co-Founder of Xperiti. He attended Columbia University.
Show more...Investment focus
- Industry: Artificial Intelligence, Cyber Security, Financial Services
- Stage:Seed, Angel, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Blyp — Blyp is an AI-driven data analytics platform for e-commerce companies.
- Vyzer — One platform for investment tracking, financial planning, data-driven insights, document analysis & more! Ideal for diverse portfolios.
- GlossAI — Detect, analyze, and monitor every brand-related video with GlossAi's Social Watching platform. Enhance your brand protection, get video insights, real-time marketing, and influencer selection. Monitor and analyze videos to elevate your brand's online presence today!
Tzachi Arabov is a owner of ACRO.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Laurence Modiano is the Member Board Of Trustees at Philharmonia Orchestra.
Show more...Investment focus
- Industry: Consulting, Health Care, Professional Services
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Droxi — Droxi is an AI-based platform that helps primary care physicians to reduce the amount of time spent on non-patient-facing tasks.
Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than 100 companies, including nineteen which have reached valuations exceeding $1 billion. His seed and early-stage investments include Illumina (ILMN);Alnylam Pharmaceuticals (ALNY); Juno Therapeutics (JUNO); Unity Biotechnology (UBX); Sienna Biopharmaceuticals (SNNA); Vir Biotechnology, Agios Pharmaceuticals (AGIO); Sage Therapeutics (SAGE); GRAIL, Ikaria; Kythera Biopharmaceuticals (KYTH), Receptos (RCPT); Aviron (AVIR); Denali Therapeutics (DNLI); Rubius Therapeutics, KSQ Therapeutics, Beam Therapeutics, NetBot; Bluebird Bio (BLUE); R2 Technology; XenoPort (XNPT); Caliper Life Sciences (CALP); Trubion Pharmaceuticals (TRBN); Adolor (ADLR); deCODE Genetics; Array BioPharma (ARRY); Editas (EDIT), IDUN Pharmaceuticals; Classmates.com; Hua Medicine; Fate Therapeutics (FATE); WuxiNextCODE; and Everyday Learning Corporation.Mr. Nelsen is a director of Vir Bio, GRAIL, Sienna Biopharmaceuticals, Beam Therapeutics, Unity Biotechnology, Denali Therapeutics, Arivale, Syros Pharmaceuticals, and serves as Chairman of Hua Medicine, among others. He previously served as a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology, and was a director of the National Venture Capital Association. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in Economics and Biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 90
- Round size: Series A $13M–$217M; Series B $20M–$200M; Series C $31M–$205M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Gameto — Gameto is a new breed of biotechnology company in female reproductive longevity
- Katalyst — With one strength training session, you'll get a full-body workout in 20 minutes, with no external loads or joint impact. The Katalyst Training System uses low frequency impulses to stimulate and contract up to 90% of the muscle fibers in your body, for an intense workout equivalent to spending 2+ hours in the gym.
- Colossal Biosciences — The science of genetics. The business of discovery.
Lily Sarafan is the Executive Chair of TheKey. She is also an Operating Partner at Cota Capital.An active Stanford alum, Lily serves on the Stanford Alumni Association Board of Directors, the Freeman Spogli Institute Council, and the Stanford Undergraduate Education Cabinet. She is also Founding Partner of Project BIG: The Stanford Brain ImmuneGut Initiative. Lily's board service extends to other high-impact nonprofits including the Women's Alzheimer's Movement and the BerkeleyHaas Center for Innovation Economies, where she is board chair. An appointee to the California Governor’s Alzheimer's Task Force, Lily serves in various leadership roles to advance economic development, civic engagement, and precision health.Lily holds an M.S. in Management Science and Engineering and B.S. in Science, Technology, and Society from Stanford University, where she was Eben Tisdale Fellow and Class President. She has been named Ernst & Young Entrepreneur of the Year, Women Health Care Executives Woman of the Year, and a Silicon Valley 40 Under 40. Lily is a Member of Young Presidents' Organization, a Term Member of the Council on Foreign Relations, a Henry Crown Fellow of the Aspen Institute, and a World Economic Forum Young Global Leader.
Show more...Investment focus
- Industry: Health Care, Wellness, Enterprise Software
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Seniorly — Seniorly helps families and older adults find the right senior living for their needs and budget. Combining the power of machine learning with the high-touch support of a national network of local advisors, Seniorly is modernizing senior living discovery. Through its online platform, Seniorly provides access to thousands of senior livingcommunities, expert insights, and personalized recommendations based search preferences. Seniorly also has a growing marketplace of trusted companies, offering other services and products that are helpful to families at this stage of life. Founded in 2014, Seniorly currently supports over 5 million visitors every year on their senior living journey. Visit http://www.seniorly.com for more information.
- January AI — January's AI health app analyzes thousands of data points to help you eat smarter and live healthier. Wear a CGM once, and January creates your "digital twin," and personalized health insights via your 24/7 AI health coach.
- NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.
Dr. Ron Sabar, founder and CMO of Sabar Health.
Show more...Investment focus
- Industry: Health Care, Bioinformatics, Personal Health
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Identifai-genetics — Revolutionizing prenatal diagnosis
Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 59
- Lead/follow: no public data
Portfolio highlights
- World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
- Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
- Endo Health — Reverse Your Diabetes With a Game
Ronald Cohen is Chairman of the Global Social Impact Investment Steering Group and The Portland Trust. He is a co-founder director of Social Finance UK (2007-11), Social Finance USA, and Social Finance Israel, and of Big Society Capital. He was co-founder Chair of Bridges Ventures (2002-2012).He chaired the Social Impact Investment Taskforceestablished under the UK’s presidency of the G8 (2013-2015), the Social Investment Task Force (2000-2010) and the Commission on Unclaimed Assets (2005-2007). In 2012 he received the Rockefeller Innovation Award for innovation in social finance.He co-founded and was Executive Chairman of Apax Partners Worldwide LLP (1972-2005). He was a founder director and Chairman of the British Venture Capital Association and a founder director of the European Venture Capital Association.He is a graduate of Oxford University, where he was President of the Oxford Union. He is an Honorary Fellow of Exeter College, Oxford. He has an MBA from Harvard Business School to which he was awarded a Henry Fellowship.He is a member of the Board of Dean’s Advisors at Harvard Business School and Vice-Chairman of Ben Gurion University. He is a former director of the Harvard Management Company and the University of Oxford Investment Committee. He is a former member of the Harvard University Board of Overseers (2007-2013), former Trustee of the British Museum (2005-2012) and a former trustee of the International Institute for Strategic Studies (2005-2011).In 2007, Sir Ronald published: “The Second Bounce of the Ball – Turning Risk into Opportunity”.
Show more...Investment focus
- Industry: Health Care, Financial Services, Apps
- Stage:Series A, Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 20
- Round size: Seed $8M–$100M; Series A $1.7M–$30M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Selina — Stay in stylish accommodations with vibrant spaces, community-driven events, and unforgettable experiences. Book your Socialtel adventure today!
- Circles - Online Group Support — Join Circles, the leading support group solution for recovery from narcissistic abuse and toxic relationships. Find support and healing today.
- Glide Identity — Transform your digital security with Glide Identity's AI-powered authentication suite. Our solutions - Magical Auth, Smart Checkout, and That's Me - deliver unmatched security with seamless user experience
Beni Nofech is a food-tech investor.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Nutrition
- Stage:Pre-Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 4
- Round size: Pre-Seed $450k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
- Oshi — Alternative Protein - Stealth Mode
- 50CUT — Mush Foods is an Israeli-based food tech company, growing edible mushroom mycelium to create innovative and sustainable animal-free protein as an ingredient for the food and beverage industry. We harness the fantastic power and innate intelligence of mushrooms to face future global challenges and provide sustainable groundbreaking food solutions tothe food of the future.
Riccardo Zacconi is based out of London, England and is the Board Member of Layer AI. Riccardo previously worked at King.com as Co-Founder and Chairman. Riccardo Zacconi attended Luiss Guido Carli University.
Show more...Investment focus
- Industry: Gaming, Apps, Mobile
- Stage:Seed, Series A, Series B
- Geography: United States, Sweden, Estonia
Investor stats
- Total investments: 19
- Round size: Seed $700k–$10M; Series A $1.2M–$30M; Series B $19M–$56M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Layer AI — The Collaborative MLOps platform
- Studio 555 — Redefining digital interior design with unrivaled technology, UX and visual fidelity
- Take Take Take — Fantasy Chess is a platform that allows users to pick teams of real-world chess players, track their performance in tournaments, and receive points based on their achievement.
Noam Soloman is the CEO and co-founder at Immunai, the first and only company to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out thousands of immune cells and their functions, building the largest proprietary data setin the world for clinical immunological data. Prior to co-founding Immunai, Noam had a dual career in both the industry and academia. Noam is a double Ph.D., and served as a post-doctoral researcher in the Mathematics department at MIT, and in the center of mathematical sciences and applications at Harvard University. In his research, he developed and applied tools from algebra and Algebraic Geometry in the study of classical problems in combinatorics. Noam also worked as an algorithms developer in the Israeli defense forces and subsequently as a data scientist, consultant and head of data science in several hi-tech companies in Israel.
Show more...Investment focus
- Industry: Software, Wellness, Health Care
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Dov Moran is the Managing Partner of Grove Ventures. He attended Technion.
Show more...Investment focus
- Industry: Hardware, Health Care, Semiconductor
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 22
- Round size: Seed $3M–$12M; Series A $1.2M–$23M; Series B $25M–$83M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Rapid — Explore your APIs
- Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
- Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
Health Care Angel investor funding in Israel at a glance
Stats across 91 deals from 99 investors.
Access all 99 angel investors in Israel Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Angel Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 99 angel investors investing in Israel Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!